Sidley Represents Apollo Funds in Minority Investment in Syntegon

Sidley is representing funds managed by Apollo as lead investor of an investor group acquiring a 37% minority stake in Syntegon, a leading global technology company serving the pharmaceutical, biotechnology, and food industries, from CVC Capital Partners.

The transaction marks the beginning of the company’s next phase of growth, with CVC retaining a majority stake of approximately 63%. Apollo’s investment will support continued expansion, particularly in North America, while reinforcing Syntegon’s position as a technology leader in highly regulated and mission-critical end markets.

Headquartered in Stuttgart, Germany, Syntegon provides integrated processing and packaging solutions and supports approximately 72,000 installed systems worldwide. Since CVC’s initial investment, the company has delivered strong performance, with revenue increasing to approximately €1.75 billion and operating profit quadrupling.

The transaction is subject to customary regulatory approvals.

Sidley’s deal team was led by partners Ramy Wahbeh and Florian Kamp, with support from senior managing associate Fran Gray (M&A/Private Equity). The broader cross-office and cross-practice team includes Björn Holland, Pedro Sacadura Botte, Mario Hirsch, Sarah Braun, Florian Haug, and Nicolas Gomez Ospina (M&A/Private Equity); Heather Palmer (Environmental, Health, and Safety); Josefine Sommer (Food, Drug and Medical Device); Jay Sadanandan, Emma Girot, Adam Abbott, and trainee solicitor Theo Sawkins (Global Finance); Lauren Kitces and Philip Robbins (Privacy and Cybersecurity); Peter Edgerton, Jason Menzies, Jörg Fischer, Avi Kaye, Megan Cox, and Andy Lau (Tax); and Paul Kariyawasam (Technology and Life Sciences Transactions).